Oct 2020 $2 M No. 5 $2 to $10 million 13
Ideal Implant Inc: Raise no. 5, Oct 2020 × Investors in this round 13 investors had bought by the notice of Oct 27, 2020: 13 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Texas People named in the notice Kevin B. Morano · Executive Officer, Director · CFO Robert S. Hamas, M.D. · Executive Officer, Director · CEO, President, Secretary, and Treasurer Paul B. Herchman · Director Wade B. Hampton · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Dr. Robert S. Hamas, M.D., CEO & President. Source: SEC Form D, newest notice filed Oct 27, 2020. Read the notice at the SEC .
equity, options SEC Mar 2020 $3 M No. 4 $2 to $10 million 17
Ideal Implant Inc: Raise no. 4, Mar 2020 × Investors in this round 17 investors had bought by the notice of May 11, 2020: 17 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $6 M offered; $2 M still to sell
Smallest investment taken $27,500
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Texas People named in the notice Kevin B. Morano · Executive Officer, Director · CFO Robert S. Hamas, M.D. · Executive Officer, Director · CEO, President, Secretary, and Treasurer Paul B. Herchman · Director Wade B. Hampton · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “This offering closed on April 24, 2020, and the remaining $2,425,000 will not be sold.”Signed by Dr. Robert S. Hamas, M.D., CEO & President. Source: SEC Form D, newest notice filed May 11, 2020. Read the notice at the SEC .
equity, options SEC Sep 2019 $4 M No. 3 $2 to $10 million 24
Ideal Implant Inc: Raise no. 3, Sep 2019 × Investors in this round 24 investors had bought by the notice of Nov 20, 2019: 24 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken $24,997
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Texas People named in the notice Kevin B. Morano · Executive Officer, Director · CFO Robert S. Hamas, M.D. · Executive Officer, Director · CEO, President, Secretary, and Treasurer Paul B. Herchman · Director Wade B. Hampton · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Dr. Robert S. Hamas, M.D., CEO & President. Source: SEC Form D, newest notice filed Nov 20, 2019. Read the notice at the SEC .
equity, options SEC Dec 2017 $5 M No. 2 $2 to $10 million 13
Ideal Implant Inc: Raise no. 2, Dec 2017 × Investors in this round 13 investors had bought by the notice of Jan 11, 2018: 13 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $8 M offered; $3 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Texas People named in the notice Kevin B. Morano · Executive Officer, Director · CFO Robert S. Hamas, M.D. · Executive Officer, Director · CEO, President, Secretary and Treasurer David B. Rasmussen, MD · Director Paul B. Herchman · Director Wade B. Hampton · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Dr. Robert S. Hamas, M.D., CEO & President. Source: SEC Form D, newest notice filed Jan 11, 2018. Read the notice at the SEC .
equity SEC May 2010 $2 M No. 1 Under $2 million 38
Ideal Implant Inc: Raise no. 1, May 2010 × Investors in this round 38 investors had bought by the notice of Jun 7, 2011: 38 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $4 M offered; $2 M still to sell
Smallest investment taken $22,500
What was sold equity
Meant to last more than a year
Issuer's revenue No revenue
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Texas People named in the notice Robert S. Hamas, M.D. · Executive Officer, Director · President, Secretary and Treasurer David L. Rasmussen. MD · Director Kevin B. Morano, MBA · Director Wade B. Hampton · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Offering amount increased to $4,000,000.”Signed by Robert S. Hamas, M.D., President. Source: SEC Form D, newest notice filed Jun 7, 2011. Read the notice at the SEC .
equity SEC